| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Thilo Schroeder last filed a Form 4 in December 2024, as Director at SPRY. The filings on record cover 3 companies. From February 2020 to December 2024, the filings on record show 10 open-market purchases and 27 sales. Thilo Schroeder's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Thilo Schroeder a strong insider score of 80/100, based on 82 past trades. Over a 12-month horizon, 93.9% of those trades were profitable, with an average 12-month return of +43.0%.
At the last filing, the largest reported position was 760,869 shares of RVMD. Net of sales, the RVMD filings show accumulation of 4,025,662 shares.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 14,619 | $30.09 | $439,821.44 | -1.3% | -18.5% | -56.3% | |
| Sep 29, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 7,461 | $30.06 | $224,251.15 | -0.7% | -22.2% | -60.1% | |
| Sep 22, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 100 | $30.00 | $3,000.00 | - | -18.1% | -58.8% | |
| Sep 17, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 711 | $30.03 | $21,351.33 | - | -22.9% | -57.3% | |
| Sep 13, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 70,828 | $30.41 | $2,154,007.16 | -5.9% | -18.9% | -53.1% | |
| Sep 2, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 46,906 | $30.25 | $1,418,687.08 | -3.8% | -31.8% | -53.1% | |
| Aug 30, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 58,829 | $30.45 | $1,791,095.25 | -4.5% | -25.9% | -54.2% | |
| Aug 25, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 51,854 | $30.87 | $1,600,943.54 | -3.2% | -19.4% | -52.9% | |
| Aug 19, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 30,664 | $33.05 | $1,013,320.15 | -1.8% | -14.9% | -49.8% | |
| Aug 17, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 80,491 | $33.89 | $2,727,673.32 | -4.6% | -30.7% | -55.6% |